StockDuty ← Dashboard Aug 21, 2026 08:51 PM ET
CatalystCorporate

KAIROS PHARMA ANNOUNCES 1-FOR-7 REVERSE STOCK SPLIT TO MAINTAIN NYSE COMPLIANCE - SEEKINGALPHA

Reverse split signals NYSE listing risk, triggering corporate action trading.

Reverse split signals NYSE listing risk, triggering corporate action trading.
Reverse split signals NYSE listing risk, triggering corporate action trading. — impact context not separately stored; see What changed.
Sources